Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes: later-stage trial registry
86 of 342 indexed Diabetes trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #19 of 28,707 conditions by registered trial count.
342 US clinical trials · 86 currently recruiting · #19 of 28,707 conditions by registered trial count
Diabetes: 342 US clinical trials tracked, 86 recruiting.
Diabetes is the subject of 342 registered US clinical trials on ClinicalTrials.gov, 86 of them currently open to new participants. 55 are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most active sponsor is Novo Nordisk A/S, running 41 of these trials.
Enrollment posture brief
Registry condition diabetes
OPEN 86 | RECR 25% | LATE 55 | EARLY 36 | RANK #19 | SPON 41
Volume-matched condition peers
Nearest open-share peer: Low Back Pain (25% recruiting · 123 trials)
Diabetes lists 86 open slots (25% of 342 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes is recruiting below its size-band peers.
86 of 342 indexed trials (25.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes trials is spread across many organizations.
Novo Nordisk A/S accounts for 41 of 342 trials (12%). 161 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes enrolment sits around 150 participants.
Median target enrolment is 150 among the 339 trials that report a genuine target (sentinel values excluded). 144 of those (42.5%) plan for fewer than 100 participants.
-
Diabetes research is mostly interventional.
263 interventional and 79 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
342 total, page 2 of 7
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
Missouri Department of Health and Senior Services
NCT06890676
Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions
University of Pittsburgh
NCT06605807
Together Overcoming Diabetes - Great Plains
Johns Hopkins Bloomberg School of Public Health
NCT06770673
Dietary Intervention to Improve Kidney Transplant Outcomes
University of California, Davis
NCT05449496
WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)
University of Florida
NCT06861790
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Bettina Mittendorfer
NCT07083557
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
Viome
NCT06185192
Imaging Histone Deacetylase in the Heart
Massachusetts General Hospital
NCT03549559
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
Albert Einstein College of Medicine
NCT05734313
Inspire HER: Inspiring the Heart and Emotions for Radical Health
University of Alabama at Birmingham
NCT06966258
Maternal Abdominal Morphology Assessment
University of Texas at Austin
NCT06784674
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
University of California, Davis
NCT04984226
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
University of Colorado, Denver
NCT06140537
Families Implementing Good Health Traditions for Life
Morehouse School of Medicine
NCT07441655
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Indiana University
NCT05643144
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
Brigham and Women's Hospital
NCT05593653
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
Rutgers, The State University of New Jersey
NCT06736431
Role of Adiposomes in Endothelial Dysfunction
University of Illinois at Chicago
NCT05199454
Mitigating the Pro-inflammatory Phenotype of Obesity
University of Kansas Medical Center
NCT04934228
Remote Fetal Monitoring in High Risk Pregnancies
Beth Israel Deaconess Medical Center
NCT06822439
Trial to Assess Chelation Therapy in Critical Limb Ischemia
Mt. Sinai Medical Center, Miami
NCT03982693
Imaging the Pathogenesis of Cerebral Small Vessel Disease
Johns Hopkins University
NCT05703386
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
M.D. Anderson Cancer Center
NCT06759701
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
Indiana University
NCT06893341
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
University of Pennsylvania
NCT04731272
Brain Blood Flow and Lactate in Non-obese and Obese Subjects
University of Missouri-Columbia
NCT06791837
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
Indiana University
NCT07119658
Supporting VETerans With Kidney Disease Through Food As Medicine
VA Eastern Colorado Health Care System
NCT07194733
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Cambridge Health Alliance
NCT06988462
Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes
Western Michigan University
NCT07063524
Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )
Wake Forest University
NCT06375694
ECHO Diabetes FQHC
University of Florida
NCT07417865
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Yale University
NCT06658067
Exciflex for Chronic Wound Therapy
VA Office of Research and Development
NCT04887688
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation
Pennington Biomedical Research Center
NCT04207619
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Midhat H. Abdulreda
NCT02846571
Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS)
National Institute on Aging (NIA)
NCT01323322
Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition
Loyola University
NCT03378765
Northern Manhattan Study of Metabolism and Mind
Columbia University
NCT02470260
Eversense® Non-adjunctive Use Post Approval Study
Senseonics
NCT04836546
BRINK (BRain In Kidney Disease) Memory Study 2.0
Anne Murray
NCT04975464
Randomized Trial of Exercise Promotion in Primary Care
Kaiser Permanente
NCT04445168
Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.
Lovoria Williams
NCT04757519
Randomized Clinical Trial to Improve Mobility After Hospitalization
University of Pennsylvania
NCT05736484
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
New York University
NCT05461495
Insulin Detemir in Obesity Management
Vanderbilt University
NCT01239550
Penn Medicine Food Market Study
University of Pennsylvania
NCT06283394
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
Methodist Health System
NCT05995262
Improving Autonomic Function and Balance in Diabetic Neuropathy
VA Office of Research and Development
NCT01864460
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
Baylor Research Institute
NCT04230694
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 13 |
| Phase 3 | 37 |
| Phase 4 | 18 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes page
342 registered trials, 86 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 86 Diabetes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novo Nordisk A/S sponsors the most Diabetes trials on record, review their full trial history before evaluating a specific study. See Novo Nordisk A/S's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes condition card totals 342 registered trials; most-linked intervention insulin degludec; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.